TMEM97 and glioma: Indeed, the silencing of TMEM97 expression in glioma U373 and U87 cells inhibited cell proliferation and cell cycle progression associated with a decrease in cyclin B1, E, CDK2 and CDK4 expression, but also in cell invasiveness.